You have 9 free searches left this month | for more free features.

Grade 1 spondylolisthesis

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients Treated With STALIF® C or M and Ti or FLX Implants for

Not yet recruiting
  • Degenerative Disc Disease
  • +3 more
  • STALIF®
  • (no location specified)
Jan 11, 2023

Lumbar Spondylolisthesis, Grade 1 Spondylolisthesis, Lumbar Spinal Stenosis Trial in Canada, United States (Expert Panel Review)

Terminated
  • Lumbar Spondylolisthesis
  • +3 more
  • Expert Panel Review
  • Scottsdale, Arizona
  • +16 more
Jul 29, 2022

Idys™ TLIF 3DTi Post Market Clinical Follow-up

Active, not recruiting
  • Degenerative Disc Disease
  • Grade 1 Spondylolisthesis
  • Spine fusion surgery with Clariance Idys TLIF 3DTi
  • College Station, Texas
    Brazos Spine
Nov 25, 2021

Complication Rates Between Lateral Approaches to Lumbar Spine

Terminated
  • Degenerative Disc Disease
  • Grade 1 Spondylolisthesis
    • (no location specified)
    Apr 2, 2021

    Degenerative Lumbar Spondylolisthesis Trial in Luxembourg (NVDX3)

    Not yet recruiting
    • Degenerative Lumbar Spondylolisthesis
    • Luxembourg, Luxembourg
      Centre Hospitalier de Luxembourg
    Jul 18, 2023

    Degenerative Spondylolisthesis G1 Trial in Shebien Elkom (PRP injection., fixation surgical procedure)

    Completed
    • Degenerative Spondylolisthesis G1
    • PRP injection.
    • fixation surgical procedure
    • Shebien Elkom, Egypt
      Dalia Saif
    Mar 18, 2021

    Spondylolisthesis Trial in Belgium, Czechia, Poland (NVD-001, Standard of Care)

    Completed
    • Spondylolisthesis
    • NVD-001
    • Standard of Care
    • Brussels, Belgium
    • +11 more
    Aug 11, 2021

    Anterior vs Posterior Surgery for Lumbar Isthmic

    Recruiting
    • Isthmic Spondylolisthesis
    • Interbody fusion surgery
    • Vancouver, British Columbia, Canada
      Vancouver General Hospital
    Jan 30, 2023

    Isthmic Spondylolisthesis Trial in Beijing (PI-LL)

    Completed
    • Isthmic Spondylolisthesis
    • PI-LL
    • Beijing, Beijing, China
      Peking University Third Hospital
    Jul 8, 2021

    Lumbar Fusion With The Icotec CF/PEEK Pedicle System In

    Completed
    • Degeneration of Lumbar Intervertebral Disc
    • Degenerative Spondylolisthesis
    • 1- or 2-level spinal fusion
    • Kiel, Schleswig-Holstein, Germany
    • +5 more
    Dec 1, 2022

    Lumbar Spinal Stenosis, Spondylolisthesis, Grade 1, Neurogenic Claudication Trial in Bryn Mawr (Pedicle Lengthening Osteotomy

    Suspended
    • Lumbar Spinal Stenosis
    • +2 more
    • Pedicle Lengthening Osteotomy with Altum® Device
    • Control
    • Bryn Mawr, Pennsylvania
      Rothman Institute
    Jul 30, 2020

    Spine Fusion, Lumbar Spondylolisthesis, Lumbar Stenosis Trial in Minneapolis (Titanium Fusion Device, PEEK Fusion Device)

    Not yet recruiting
    • Spine Fusion
    • +2 more
    • Titanium Fusion Device
    • PEEK Fusion Device
    • Minneapolis, Minnesota
      Twin Cities Spine Center
    Jan 18, 2023

    Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)

    Not yet recruiting
    • Essential Hypertension
    • NW Roselle
    • Captopril 25Mg Tab
    • (no location specified)
    Nov 15, 2023

    Recurrent High Grade Glioma Trial (MVR-C5252)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • MVR-C5252
    • (no location specified)
    Nov 6, 2023

    Endometrial Cancer Trial (Giredestrant)

    Not yet recruiting
    • Endometrial Cancer
    • (no location specified)
    Feb 1, 2023

    Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)

    Recruiting
    • Low-Grade Glioma
    • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 24, 2022

    Osteoarthritis, Knee Trial in Islamabad (Kinesio Taping, Dry Needling)

    Completed
    • Osteoarthritis, Knee
    • Kinesio Taping
    • Dry Needling
    • Islamabad, Islamabad Capital Territory, Pakistan
      Riphah International University (RIU)
    Oct 11, 2023

    Glioblastoma, High-grade Glioma Trial in Groningen (Cetuximab-IRDye800)

    Recruiting
    • Glioblastoma
    • High-grade Glioma
    • Groningen, Netherlands
      UMCG
    Jun 26, 2023

    Treatment of Symptoms of Grade 2 and Grade 3 Late Xerostomia From Salivary Gland Hypofunction Caused by Radiotherapy for Cancer

    Recruiting
    • Treatment of Symptoms of Grade 2 and Grade 3 Late Xerostomia From Salivary Gland Hypofunction Caused by Radiotherapy for Cancer of the Oropharynx
    • AAV2-hAQP1 Concentration 1
    • +2 more
    • Charlotte, North Carolina
      Atrium Health
    Jun 22, 2023

    Low-grade Glioma Trial in Toronto (Saturation Transfer (ST)-MRI)

    Recruiting
    • Low-grade Glioma
    • Saturation Transfer (ST)-MRI
    • Toronto, Ontario, Canada
    • +1 more
    Aug 10, 2023

    Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)

    Not yet recruiting
    • Hypertension,Essential
    • Songling Xuemaikang Capsules
    • +2 more
    • Beijing, Beijing, China
    • +4 more
    Oct 17, 2023

    Endometrial Carcinoma Trial (Lerociclib, Letrozole 2.5mg, Placebo)

    Not yet recruiting
    • Endometrial Carcinoma
    • (no location specified)
    Jan 26, 2023

    Endometrial Cancer, Atypical Hyperplasia Trial (Ozempic, Mirena)

    Not yet recruiting
    • Endometrial Cancer
    • Atypical Hyperplasia
    • (no location specified)
    Oct 3, 2023

    Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

    Active, not recruiting
    • Ann Arbor Stage I Grade 1 Follicular Lymphoma
    • +3 more
    • Clinical Observation
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)

    Not yet recruiting
    • Low Grade Glioma of Brain
    • PEPIDH1M vaccine + vorasidenib
    • Durham, North Carolina
      Duke University Medical Center
    Nov 2, 2022